Research-use-only context. This article is an educational research overview. It provides no administration or usage guidance for any human or animal use and makes no therapeutic or efficacy claims. American Peptides products are sold strictly for in vitro laboratory research only.
Intranasal delivery administers a peptide solution as a metered spray to the nasal mucosa — a thin, richly vascular lining that can absorb a fraction of the peptide rapidly and, for certain small peptides, is studied for direct nose-to-brain transport. In pharmacokinetic research it is characterized as a needle-free route with moderate bioavailability and fast onset in research models, which is why peptides like Selank and Semax are so often studied in nasal-spray form.
The anatomy that makes the nasal route work
The nasal cavity is lined by two functionally distinct epithelia: the respiratory epithelium across most of the cavity, and the olfactory epithelium high in the nasal vault. Both sit over a dense capillary bed just microns beneath the surface. That combination — large surface area, thin lining, heavy vascularization — is what allows a fraction of a deposited peptide to move into local circulation quickly, without first passing through the gut.
How absorption is characterized
Research describes two broad transport patterns across the nasal lining: paracellular movement between epithelial cells and transcellular movement through them. Separately, the olfactory region is studied for a nose-to-brain pathway, in which a small fraction of certain molecules is examined for transport along olfactory and trigeminal routes. This nose-to-brain interest is a major reason small neuropeptides are studied intranasally rather than by other needle-free formats.
What limits nasal bioavailability
The intranasal route sits between the parenteral and oral routes on bioavailability, and several factors govern where a given peptide lands:
| Factor | Effect on the research characterization |
|---|---|
| Volume per actuation | The nasal cavity holds a small volume, capping how much can be deposited at once |
| Mucosal clearance | The mucus layer continuously moves fluid toward the throat, shortening contact time |
| Molecular size | Smaller peptides cross the epithelium more readily than large ones |
| Formulation | Solution properties influence residence time and absorption in research settings |
For a side-by-side of the nasal route against the parenteral and oral formats, see Peptide Delivery Methods Explained.
Which peptides are studied intranasally
Small, water-soluble neuropeptides are the classic candidates. The two most common in research catalogs are Selank and Semax — both short synthetic peptides examined for central-signaling pathways, which is exactly the profile the nose-to-brain literature is interested in. American Peptides offers all three research nasal-spray formats, pre-mixed and needle-free:
Browse the needle-free lineup: Needle-Free Peptides & Dissolving Strips →
Frequently Asked Questions
What is intranasal peptide delivery?
Intranasal peptide delivery is the administration of a peptide solution as a metered spray to the nasal mucosa. The thin, vascular nasal lining absorbs a fraction of the peptide rapidly and needle-free, without passing it through the digestive tract, which is why it is a widely studied research route.
Why are peptides given as nasal sprays in research?
The nasal route is needle-free, requires no reconstitution, and absorbs small peptides quickly across a richly vascular lining. For certain small neuropeptides it is also studied for a direct nose-to-brain transport pathway, which makes the format especially relevant to central-signaling research.
What is nose-to-brain delivery?
Nose-to-brain delivery refers to a studied pathway in which a small fraction of certain molecules deposited on the olfactory region of the nasal cavity is examined for transport along olfactory and trigeminal routes. It is an active area of research characterization, not an established human-use route.
How much of a nasal-spray peptide is absorbed?
Intranasal bioavailability is characterized as moderate — higher than swallowed oral for most peptides, lower than the parenteral route — and varies with molecular size, volume per actuation, mucosal clearance, and formulation.
Which peptides come in nasal-spray form?
Small synthetic neuropeptides such as Selank and Semax are the most common research peptides studied and offered as nasal sprays, because their size and water solubility suit the intranasal route.
Related reading: What Is Selank? · What Is Semax? · Peptide Delivery Methods Explained. Verify identity and purity for any format on the COA library.
Reviewed by the American Peptides Education Team. Educational content only — not medical advice.
This article is for laboratory research reference only. American Peptides research peptides are sold strictly for in vitro research and are not for human consumption.
Compliance Notice: American Peptides research peptides are sold strictly for laboratory and academic research purposes only. They are not intended for human or veterinary consumption, diagnosis, treatment, or prevention of any disease. All content on this page is educational in nature and does not constitute medical advice or product claims. Researchers are responsible for handling these compounds in accordance with their institution's safety protocols and applicable laws.
